Variant report

Variant	esv1835393
Chromosome Location	chr4:93222515-93276174
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:261)
CpG islands
(count:1281)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:261 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:93245399-93245438	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr4:93225729-93225802	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr4:93268962-93269119	IMR90	lung:	n/a	n/a
4	CEBPB	chr4:93265375-93265692	HepG2	liver:	n/a	chr4:93265543-93265560 chr4:93265546-93265559 chr4:93265546-93265557
5	CEBPB	chr4:93265429-93265715	A549	lung:	n/a	chr4:93265543-93265560 chr4:93265546-93265559 chr4:93265546-93265557
6	CEBPB	chr4:93228958-93229192	HepG2	liver:	n/a	chr4:93229010-93229023
7	CEBPB	chr4:93265394-93265689	IMR90	lung:	n/a	chr4:93265543-93265560 chr4:93265546-93265559 chr4:93265546-93265557
8	CEBPB	chr4:93223357-93223587	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr4:93265403-93265683	K562	blood:	n/a	chr4:93265543-93265560 chr4:93265546-93265559 chr4:93265546-93265557
10	CEBPB	chr4:93252150-93252172	IMR90	lung:	n/a	n/a
11	CEBPB	chr4:93226282-93227059	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr4:93233054-93233236	HepG2	liver:	n/a	n/a
13	CHD1	chr4:93225639-93226298	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD1	chr4:93226522-93227254	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD1	chr4:93224755-93225223	H1-hESC	embryonic stem cell:	n/a	chr4:93225075-93225085
16	CHD2	chr4:93226571-93227000	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr4:93224859-93225056	H1-hESC	embryonic stem cell:	n/a	n/a
18	CREB1	chr4:93226449-93227168	H1-hESC	embryonic stem cell:	n/a	n/a
19	CREB1	chr4:93226342-93227057	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTBP2	chr4:93224813-93227536	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr4:93226720-93226870	HRE	kidney:	n/a	chr4:93226797-93226815
22	CTCF	chr4:93224800-93224950	BE2_C	brain:	n/a	n/a
23	CTCF	chr4:93224716-93224990	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr4:93226065-93226148	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr4:93254100-93254250	HBMEC	blood vessel:	n/a	n/a
26	CTCF	chr4:93224700-93224850	BE2_C	brain:	n/a	n/a
27	CTCF	chr4:93226700-93226850	HRPEpiC	eye:	n/a	chr4:93226797-93226815
28	CTCF	chr4:93226300-93226450	WERI-Rb-1	eye:	n/a	n/a
29	CTCF	chr4:93224740-93224890	HCM	heart:	n/a	n/a
30	CTCF	chr4:93226480-93226630	WERI-Rb-1	eye:	n/a	n/a
31	CTCF	chr4:93239820-93239900	Medullo	brain:	n/a	n/a
32	CTCF	chr4:93224760-93224910	HPAF	blood vessel:	n/a	n/a
33	CTCF	chr4:93226700-93226850	SK-N-SH_RA	brain:	n/a	chr4:93226797-93226815
34	CTCF	chr4:93226260-93226410	SK-N-SH_RA	brain:	n/a	n/a
35	CTCF	chr4:93224800-93224950	HEK293	kidney:	n/a	n/a
36	CTCF	chr4:93226721-93226891	MCF-7	breast:	n/a	chr4:93226797-93226815
37	CTCF	chr4:93226740-93226890	HBMEC	blood vessel:	n/a	chr4:93226797-93226815
38	CTCF	chr4:93224820-93224970	AG04449	skin:	n/a	n/a
39	CTCF	chr4:93226720-93226870	WERI-Rb-1	eye:	n/a	chr4:93226797-93226815
40	CTCF	chr4:93227240-93227390	HRE	kidney:	n/a	chr4:93227299-93227312
41	CTCF	chr4:93224780-93224930	SK-N-SH_RA	brain:	n/a	n/a
42	CTCF	chr4:93226220-93226370	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr4:93224800-93224950	HRPEpiC	eye:	n/a	n/a
44	CTCF	chr4:93227140-93227290	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr4:93224720-93224870	HMF	breast:	n/a	n/a
46	CTCF	chr4:93226711-93226912	MCF-7	breast:	n/a	chr4:93226797-93226815
47	CTCF	chr4:93226340-93226490	WERI-Rb-1	eye:	n/a	n/a
48	CTCF	chr4:93224660-93224810	AG04450	lung:	n/a	n/a
49	CTCF	chr4:93224740-93224890	WERI-Rb-1	eye:	n/a	n/a
50	CTCF	chr4:93224720-93224870	HRPEpiC	eye:	n/a	n/a

(count:1281 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:93225565-93225615	NH-A	brain:	n/a
2	chr4:93227270-93227320	LNCaP	prostate:	n/a
3	chr4:93225360-93225410	AG09309	skin:	n/a
4	chr4:93226926-93226976	HRE	kidney:	n/a
5	chr4:93224987-93225037	Hepatocyte	liver:	n/a
6	chr4:93226889-93226939	HAEpiC	amniotic membrane:	n/a
7	chr4:93225086-93225136	SAEC	small airway:	n/a
8	chr4:93227270-93227320	HL-60	blood:	n/a
9	chr4:93226540-93226590	IMR90	lung:	fetal
10	chr4:93227195-93227245	HRCEpiC	kidney:	n/a
11	chr4:93226495-93226545	HUVEC	blood vessel:	n/a
12	chr4:93226889-93226939	LNCaP	prostate:	n/a
13	chr4:93225960-93226010	NHDF-neo	bronchial:	n/a
14	chr4:93225960-93226010	MCF10A-Er-Src	breast:	n/a
15	chr4:93225086-93225136	ProgFib	skin:	n/a
16	chr4:93229269-93229319	HCPEpiC	choroid plexus:	n/a
17	chr4:93225960-93226010	Jurkat	blood:	n/a
18	chr4:93226245-93226295	HCF	heart:	n/a
19	chr4:93226926-93226976	AG10803	skin:	n/a
20	chr4:93225360-93225410	IMR90	lung:	fetal
21	chr4:93226245-93226295	GM06990	blood:	n/a
22	chr4:93226625-93226675	Caco-2	colon:	n/a
23	chr4:93225086-93225136	NH-A	brain:	n/a
24	chr4:93225360-93225410	LNCaP	prostate:	n/a
25	chr4:93225565-93225615	PFSK-1	brain:	n/a
26	chr4:93226245-93226295	PrEC	prostate:	n/a
27	chr4:93227270-93227320	HAEpiC	amniotic membrane:	n/a
28	chr4:93226245-93226295	HepG2	liver:	n/a
29	chr4:93224987-93225037	GM12878	blood:	n/a
30	chr4:93226380-93226430	AG09309	skin:	n/a
31	chr4:93226889-93226939	AG10803	skin:	n/a
32	chr4:93225157-93225207	AG04449	skin:	fetal
33	chr4:93224895-93224945	NHDF-neo	bronchial:	n/a
34	chr4:93225960-93226010	NT2-D1	testis:	n/a
35	chr4:93225466-93225516	ovcar-3	ovarian:	n/a
36	chr4:93226540-93226590	HCT-116	colon:	n/a
37	chr4:93224058-93224108	HMEC	breast:	n/a
38	chr4:93226926-93226976	HMEC	breast:	n/a
39	chr4:93227195-93227245	HPAEpiC	pulmonary alveolar:	n/a
40	chr4:93224895-93224945	AG10803	skin:	n/a
41	chr4:93224987-93225037	GM06990	blood:	n/a
42	chr4:93227195-93227245	MCF-7	breast:	n/a
43	chr4:93225933-93225983	SAEC	small airway:	n/a
44	chr4:93226540-93226590	U87	brain:	n/a
45	chr4:93227270-93227320	K562	blood:	n/a
46	chr4:93226889-93226939	PrEC	prostate:	n/a
47	chr4:93226540-93226590	HMEC	breast:	n/a
48	chr4:93225933-93225983	HCM	heart:	n/a
49	chr4:93225960-93226010	PrEC	prostate:	n/a
50	chr4:93224987-93225037	Caco-2	colon:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:93202258..93204813-chr4:93248472..93250667,2	K562	blood:
2	chr4:93230221..93231021-chr4:93539897..93540682,3	MCF-7	breast:
3	chr4:93232082..93235145-chr4:93236443..93238275,3	K562	blood:
4	chr4:93253053..93255053-chr4:93257043..93259264,2	MCF-7	breast:
5	chr4:93253053..93255053-chr4:93257043..93259264,2	MCF-7	breast:
6	chr4:93232082..93235145-chr4:93236443..93238275,3	K562	blood:
7	chr4:93254754..93257584-chr4:93259309..93261079,2	MCF-7	breast:
8	chr4:93254754..93257584-chr4:93259309..93261079,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000248511	TF binding region
GRID2	TF binding region
ENSG00000248511	CpG island
GRID2	CpG island

Extended variants
information (count: 1963 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:1963 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9990511	chr4:93222515-93222516	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs559842960	chr4:93222550-93222551	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs140311945	chr4:93222570-93222571	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs554863192	chr4:93222591-93222592	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs574753995	chr4:93222658-93222659	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs187723865	chr4:93222668-93222669	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs35214260	chr4:93222694-93222695	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs545025560	chr4:93222738-93222739	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs117484658	chr4:93222744-93222745	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs548833750	chr4:93222796-93222797	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs576920472	chr4:93222902-93222903	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs191250133	chr4:93223074-93223075	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs145357356	chr4:93223243-93223244	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs72055408	chr4:93223261-93223262	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs59958110	chr4:93223265-93223266	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs150945218	chr4:93223272-93223273	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs183796212	chr4:93223300-93223301	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs562073875	chr4:93223370-93223371	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs531406603	chr4:93223399-93223400	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs187682173	chr4:93223422-93223423	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs550602114	chr4:93223502-93223503	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs367789554	chr4:93223572-93223573	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs564135521	chr4:93223582-93223583	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs571179466	chr4:93223583-93223584	Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs570398735	chr4:93223614-93223615	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs533129151	chr4:93223626-93223627	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs538294348	chr4:93223628-93223629	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs547078797	chr4:93223678-93223679	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs566817035	chr4:93223680-93223681	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs534838013	chr4:93223739-93223740	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs548381252	chr4:93223746-93223747	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs568395194	chr4:93223756-93223757	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs537330388	chr4:93223805-93223806	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs557248917	chr4:93223921-93223922	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs576926558	chr4:93223943-93223944	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs539030868	chr4:93224056-93224057	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs150079003	chr4:93224058-93224059	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs554029261	chr4:93224064-93224065	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs565861818	chr4:93224101-93224102	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs572829676	chr4:93224123-93224124	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs542445282	chr4:93224204-93224205	Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs561936126	chr4:93224238-93224239	Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs575580448	chr4:93224262-93224263	Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs544506241	chr4:93224334-93224335	Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs564398448	chr4:93224344-93224345	Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs140742721	chr4:93224477-93224478	Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs533376763	chr4:93224492-93224493	Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs537754533	chr4:93224499-93224500	Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs540235293	chr4:93224512-93224513	Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs560661535	chr4:93224722-93224723	Active TSS Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
primary effusion lymphomas	17116491	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Olfactory neuroblastoma	18408657	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
Acute monocytic leukemia	16498392	CNVD
Multiple myeloma	16616336	CNVD
Esophageal adenocarcinoma	18820669	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Parkinson disease	20877625	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	20164920	CNVD
Cancer	20164919	CNVD
Esophageal cancer	21851588	CNVD
Cancer	19907438	CNVD
early-passage human iPS cells	21368824	CNVD
Williams Syndrome	20824207	CNVD

Chromatin state (count:596 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:93217800-93223400	Weak transcription	HUES6 Cell Line	embryonic stem cell
2	chr4:93218000-93223400	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr4:93218200-93223000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
4	chr4:93220600-93222800	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr4:93221200-93223600	Enhancers	iPS-20b Cell Line	embryonic stem cell
6	chr4:93221200-93224600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
7	chr4:93221600-93223600	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr4:93222000-93222800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
9	chr4:93222200-93223200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
10	chr4:93222800-93223000	Enhancers	Brain Anterior Caudate	brain
11	chr4:93222800-93223600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
12	chr4:93222800-93223800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
13	chr4:93223000-93223600	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr4:93223000-93223600	Weak transcription	Brain Anterior Caudate	brain
15	chr4:93223200-93224400	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr4:93223400-93223800	Enhancers	HUES6 Cell Line	embryonic stem cell
17	chr4:93223400-93224200	Enhancers	H9 Cell Line	embryonic stem cell
18	chr4:93223600-93223800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
19	chr4:93223600-93223800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr4:93223600-93223800	Enhancers	Brain Angular Gyrus	brain
21	chr4:93223600-93224000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
22	chr4:93223600-93224000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
23	chr4:93223600-93224000	Enhancers	Brain Cingulate Gyrus	brain
24	chr4:93223600-93224000	Enhancers	Brain Substantia Nigra	brain
25	chr4:93223600-93224200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
26	chr4:93223600-93224400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
27	chr4:93223600-93224400	Enhancers	H1 Cell Line	embryonic stem cell
28	chr4:93223600-93224400	Enhancers	Brain Anterior Caudate	brain
29	chr4:93223800-93224000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
30	chr4:93223800-93224000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
31	chr4:93223800-93224200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
32	chr4:93223800-93224200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
33	chr4:93223800-93224400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
34	chr4:93223800-93224400	Weak transcription	Brain Angular Gyrus	brain
35	chr4:93223800-93224800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr4:93224000-93224200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
37	chr4:93224000-93224200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
38	chr4:93224000-93224400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr4:93224000-93224600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr4:93224000-93224600	Weak transcription	Brain Cingulate Gyrus	brain
41	chr4:93224000-93224800	Weak transcription	Brain Substantia Nigra	brain
42	chr4:93224000-93228600	Active TSS	ES-I3 Cell Line	embryonic stem cell
43	chr4:93224200-93224400	Active TSS	HUES6 Cell Line	embryonic stem cell
44	chr4:93224200-93224400	Enhancers	iPS-18 Cell Line	embryonic stem cell
45	chr4:93224200-93224400	Enhancers	Cortex derived primary cultured neurospheres	brain
46	chr4:93224200-93224600	Weak transcription	H9 Cell Line	embryonic stem cell
47	chr4:93224200-93225400	Active TSS	iPS-20b Cell Line	embryonic stem cell
48	chr4:93224200-93227800	Active TSS	HUES48 Cell Line	embryonic stem cell
49	chr4:93224400-93224600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
50	chr4:93224400-93224600	Enhancers	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links